Answers are grounded in this paper and cite their sources.
Matrix metalloproteinases (MMPs) are enzymes involved in physiological and pathological processes, including cancer progression. In particular, MMP9 is positioned as a relevant biomarker in cancer diagnosis and prognosis. This project presents the development of a label-free electrochemical immunosensor for the detection of MMP9. For the construction of the immunosensor, an electrografting methodology is used to modify the surface of the screen-printed electrode, followed by activation by EDC/NHSS, which allows specific immobilization of the capture antibody and blocking of non-reactive sites with bovine serum albumin. The correct modification of the electrode surface in the biosensor preparation steps was confirmed by cyclic voltammetry and electrochemical impedance spectroscopy. The quantitative analysis was carried out by square wave voltammetry, obtaining an accurate biosensor platform (1 ng/mL CV=10%; 50 ng/mL CV=5%), high sensitivity (2,85 µA·mL/ng), low detection limit (0.301 ng/mL), and excellent recovery results (1 ng/mL 95%; 10 ng/mL 109,2%, 100 ng/mL 96,5%).
No takes yet. Share an insight, caveat, or question.
López-Ruíz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: